
Kyowa Hakko Bio reveals new EMEA hub and sharpened cognitive health focus
Biotechnology and health science company Kyowa Hakko Bio Co. Ltd has positioned its Italian subsidiary as the firm’s central commercial hub for EMEA with new management and an increased focus on its cognitive health ingredient Cognizin.













































